NIH Wants Your Take on Cataloging 26,000 Genetic Weirdness Tests
Published Date: 1/22/2026
Notice
Summary
The National Institutes of Health wants your thoughts on keeping their Genetic Testing Registry going strong! This online hub helps labs and researchers share info about genetic tests for over 26,000 conditions. If you have ideas or concerns, speak up by March 23, 2026—no cost involved, just your voice!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Laboratories face time-only reporting burden
Laboratories, test developers, manufacturers, and researchers may voluntarily submit information to the NIH Genetic Testing Registry. NIH estimates a total annualized respondent burden of 2,837 hours across 402 respondents and 6,432 responses; OMB approval is requested for 3 years and there are no costs to respondents other than their time.
Clinicians get centralized genetic-test information
The Genetic Testing Registry gives clinicians and researchers a single online place to find details about tests for over 26,000 genetic conditions, including tests for microbes such as SARS-CoV-2 used to diagnose COVID-19. The registry provides information on test accuracy, validity, and usefulness and highlights evidence gaps where more research is needed.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
Previous / Next Documents
Previous: 2026-01108 — Denali Commission Fiscal Year 2026 Draft Work Plan
The Denali Commission is planning for 2026 with a backup plan since the President’s budget didn’t include new money, but Congress might still fund it. This affects Alaska’s remote communities by aiming to keep important services and infrastructure running smoothly. People have until February 23, 2026, to share their thoughts on the draft plan before final decisions are made.
Next: 2026-01110 — Foreign-Trade Zone (FTZ) 45, Notification of Proposed Production Activity; Qorvo US, Inc.; (Semiconductor Wafers and Modules); Hillsboro, Oregon
Qorvo US, Inc. in Hillsboro, Oregon, wants to start making special semiconductor wafers and modules using certain imported materials under Foreign-Trade Zone rules. This move helps them save on import duties (some as high as 2.8%) and speeds up production. The government is reviewing their plan, which was submitted in January 2026, to approve these cost-saving changes.